Tuesday, December 06, 2022
Outlook.com
Outlook India
Outlook Business
+

PharmEasy Floats Rights Issue To Raise Rs 750 Crore

The company’s existing investors like Prosus Ventures and Temasek as well as its founders have subscribed to the issue for shares worth about Rs 200 crore

PharmEasy Floats Rights Issue To Raise Rs 750 Crore
POSTED ON October 05, 2022 7:37 PM

Online pharmacy start-up PharmEasy has kicked off its rights issue to raise up to Rs 750 crore through convertible notes. The issue will close by the middle of October, according to reports.

The company’s existing investors like Prosus Ventures and Temasek as well as its founders have subscribed to the issue for shares worth about Rs 200 crore, according to an Economic Times report.

Prosus Ventures and Temasek have subscribed to convertibles worth nearly Rs 100 crore and Rs 90 crore, respectively. Share subscription through convertible notes means PharmEasy’s valuation has not been priced in yet.

The company will be valued at its last valuation if it doesn’t raise new capital by March 31, 2023, the report said.

The new funding round for PharmEasy seems unsure currently as markets are not conducive from a valuation perspective. Late-stage deal activity has slowed down significantly and investors are being cautious about higher valuations, the report cited people close to the matter as saying.

  • Related Articles

    Square Off Chess is a physical chessboard which is connected to its app and enables users to play against the board or anyone from across the globe

    Robotics Startup Miko Acquires Chessboard Maker Square Off: Report

    The four shortlisted start-ups include FermionIC Design Pvt Ltd, Powency Circuit Private Limited, Pantherun Technologies Pvt Ltd and Simyog Technology Private Limited

    Qualcomm Selects Four Semiconductor Start-Ups For Mentorship Program

    Rebel Foods runs nearly 4,000 cloud kitchens across 45 brands and entered the unicorn club last year

    Rebel Foods Raises Rs 75 Crore from Alteria Capital